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Dear Editor, 
Proteins of the peroxisome proliferator-activated receptor γ coactivator 1 (PGC1) family are 
transcriptional coactivators well known for regulating mitochondrial biogenesis and other metabolic 
functions in multiple tissues 1. Recently, PGC1 coactivators have also been linked to pigmentation 
and melanoma skin cancer. In a genome-wide association study 2, our group determined the A allele 
of SNP rs32579 in the PGC1β gene was significantly associated with greater tanning ability, which 
was successfully replicated in additional samples 3. Furthermore, we demonstrated that the rs32579 A 
allele was correlated with upregulation of PGC1β gene expression and lower risk of melanoma 3. 
However, whether this SNP influences risk of melanoma death remains a question of interest. 
We thus investigated the association between the genetic variant rs32579 A and melanoma 
mortality among 858 melanoma cases. All patients were accrued from a hospital-based case-control 
study of melanoma skin cancer at The University of Texas MD Anderson Cancer Center (MDACC). 
Melanoma-specific death was the primary endpoint of the current analysis. We calculated survival 
time from the date of diagnosis to the date of death from melanoma or the date of the last follow-up, 
whichever came first. Multivariate Cox proportional hazards regression models, adjusted for age, sex, 
tumor stage, Breslow thickness, tumor cell mitotic rate, and top two principal components of genetic 
variance, were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the 
association between rs32579 and melanoma mortality. Our result showed that A allele was associated 
with a lower risk of melanoma disease-specific death (Table 1, HR=0.64, 95% CI=0.45-0.91, 
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p-value=0.013). Previously, the telomere-mitochondrion connection was shown to be regulated by 
PGC1s 4, and telomere length was positively correlated with nevus count 5. We therefore further 
examined the possible association between this variant and nevus count, a well-known risk factor for 
malignant melanoma. Among 15,952 individuals of European Ancestry in the Nurses’ Health Study 
(NHS) and the Health Professionals Follow-up Study (HPFS), the number of nevi decreases by 0.06 
per each A allele (p-value=0.018). Detailed methods of this additional analysis on nevus count have 
been described previously 6. Information on study population, genotyping procedure, quality control 
and imputation are provided in Supplementary Materials, for the MDACC study, the NHS and the 
HPFS. 
PGC1β and PGC1α normally co-express with each other, and they share a large degree of 
sequence homology and functional overlap 1. PGC1α-positive melanomas have been found to have 
higher rates of survival under oxidative stress compared to PGC1α-negative melanoma 7. Last year, 
Luo et al. reported that PGC1α suppressed melanoma metastasis through direct regulation of 
parallel-acting transcriptional programs 8. Though not on PGC1β, these findings may support our 
observations in the current population study. 
 In summary, we so far have shown that this SNP was associated with tanning ability, nevus 
count, and both melanoma risk and mortality, which further emphasizes the critical role of PGC1s in 
multiple steps of melanocyte formation and melanoma development. BRAF inhibition regulates 
PGC1α expression in BRAF-mutated melanoma, which affects the therapeutic efficacy of BRAF 
inhibitors 9. Future studies are warranted to investigate the effect modification of this PGC1β variant 
on BRAF inhibitors in melanoma treatment. 
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 Table 1. Association between PGC1β rs32579 # and melanoma-specific death 
Genotype No. of patients 
No. of 
deaths HR (95%CI) * P-value 
GG 454 56 1.00 (Ref) 
 
GA 331 34 0.62 (0.40-0.97)  
AA 73 5 0.44 (0.17-1.10)  
Additive model  
(G – ref allele, A – test allele)   0.64 (0.45-0.91) 0.013 
# SNP rs32579 is located on chromosome 5 with BP position at 149210848. The G allele is the 
major allele, and the A allele is the minor allele. Minor allele frequency = 0.28. 
* Cox proportional hazards regression model, adjusted for age, sex, tumor stage, Breslow 
thickness, tumor cell mitotic rate, and the top two principal components.  
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